Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EVT801 + unspecified PD-1 antibody |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EVT801 | EVT-801|EVT 801 | VEGFR3 Inhibitor 6 | EVT801 inhibits FLT4 (VEGFR3), potentially resulting in enhanced antitumor immune response, and inhibition of tumor angiogenesis and tumor development (Cancer Res 2019;79(13 Suppl):Abstract nr 4079; Cancer Res 2017;77(13 Suppl):Abstract nr 2634). | |
| unspecified PD-1 antibody | Experimental PD-1 antibody | Immune Checkpoint Inhibitor 150 PD-L1/PD-1 antibody 133 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|